FIELD: medicine.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, and concerns medication for treatments of malignant neoplasms. Claimed medication contains DL-α-amino-β{p-di(2-chlorethyl)aminophenoxy]phenyl}-propionic acid dihydrochloride and additives. As additives starch, talc, aerosyl, calcium stearite and sodium chloride are used. Claimed medication possesses high anti-tumor activity, low toxicity, is convenient in application.
EFFECT: producing medication, which possesses high antitumor activity with low toxicity.
4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF PATIENTS SUFFERED FROM MYELOMA | 1998 |
|
RU2127588C1 |
ANTITUMOR AGENT | 1999 |
|
RU2144821C1 |
ANTICANCER DRUG FOR ORAL USE | 2020 |
|
RU2748989C1 |
AGENT FOR TREATING OESTROGEN-DEPENDENT CANCER | 2012 |
|
RU2510268C1 |
ANTICANCER PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2419430C2 |
ANTITUMOR AGENT | 1996 |
|
RU2093158C1 |
PREPARATION WITH ENHANCED TOLERANCE IN VIVO | 1998 |
|
RU2234322C2 |
ANTI-TUMOUR PREPARATION | 2014 |
|
RU2569729C1 |
ORAL ANTITUMOUR DRUGS AND METHOD FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2639479C1 |
ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
Authors
Dates
2008-10-10—Published
2007-05-14—Filed